Background
Cardiac cirrhosis (congestive hepatopathy) includes a spectrum of hepatic derangements that occur in the setting
of right-sided heart failure. Clinically, the signs and symptoms of congestive heart failure (CHF) dominate the
disorder. Unlike cirrhosis caused by chronic alcohol use or viral hepatitis, the effect of cardiac cirrhosis on overall
prognosis has not been clearly established. As a result, treatment is aimed at managing the underlying heart
failure.
Distinguishing cardiac cirrhosis from ischemic hepatitis is important. The latter condition may involve massive
hepatocellular necrosis caused by sudden cardiogenic shock or other hemodynamic collapse. Typically, sudden
and dramatic serum hepatic transaminase elevations lead to its discovery. Although cardiac cirrhosis and
ischemic hepatitis arise from distinct underlying cardiac lesions (right-sided heart failure in the former and leftsided failure in the latter), in clinical practice they may present together.
Despite its name, cardiac cirrhosis (which usually implies congestive hepatopathy that results in liver fibrosis)
rarely satisfies strict pathologic criteria for cirrhosis. The terms congestive hepatopathy and chronic passive liver
congestion are more accurate, but the name cardiac cirrhosis has become convention. For the remainder of this
chapter, the term cardiac cirrhosis will be used to mean congestive hepatopathy with or without liver fibrosis.
Pathophysiology
Decompensated right ventricular or biventricular heart failure causes transmission of elevated right atrial pressure
http://emedicine.medscape.com/article/151792-overview
1/4
8/25/2014
to the liver via the inferior vena cava and hepatic veins. At a cellular level, venous congestion impedes efficient
drainage of sinusoidal blood flow into terminal hepatic venules. Sinusoidal stasis results in accumulation of
deoxygenated blood, parenchymal atrophy, necrosis, collagen deposition, and, ultimately, fibrosis.
A separate theory proposes that cardiac cirrhosis is not simply a response to chronically increased pressure and
sinusoidal stasis. Because intrahepatic vascular lesions are confined to areas of the liver with higher fibrotic
burden, cardiac cirrhosis may require a higher grade of vascular obstruction, such as intrahepatic thrombosis, for
its development. Thus, thrombosis of sinusoids and terminal hepatic venules propagates to medium-sized hepatic
veins and to portal vein branches, resulting in parenchymal extinction and fibrosis.
Epidemiology
Frequency
United States
Cardiac cirrhosis rarely occurs in the United States. Its true prevalence is difficult to estimate, since the disease
typically remains subclinical and undiagnosed. The incidence of cardiac cirrhosis at autopsy has decreased
significantly over the past several decades. This may be due to lower rates of uncorrected rheumatic heart disease
and constrictive pericardial disease.
Mortality/Morbidity
The effect of cardiac cirrhosis on mortality and morbidity rates is unknown. The severity of the patient's underlying
cardiac disease, which is typically advanced and chronic, is the major determinant of overall outcome.
Sex
Comparative sex data for cardiac cirrhosis do not exist. However, because CHF is more common in men than
women in the United States, the same is likely for cardiac cirrhosis.[1]
Age
No published data exist. However, the prevalence of cardiac cirrhosis in the United States, like that of CHF, almost
certainly increases with age.
http://emedicine.medscape.com/article/151792-overview
2/4
8/25/2014
References
1. Burns RB, McCarthy EP, Moskowitz MA. Outcomes for older men and women with congestive heart
failure. J Am Geriatr Soc. Mar 1997;45(3):276-80. [Medline] .
2. Shapira, Y, Porter, A, Wurzel, M. Evaluation of tricuspid regurgitation severity: echocardiographic and
clinical correlation. J Am Soc Echocardiogr. Jun 1998;11(6):652-9. [Medline] .
3. Runyon BA. Cardiac ascites: a characterization. J Clin Gastroenterol. Aug 1988;10(4):410-2. [Medline] .
4. Wanless IR, Liu JJ, Butany J. Role of thrombosis in the pathogenesis of congestive hepatic fibrosis
(cardiac cirrhosis). Hepatology. May 1995;21(5):1232-7. [Medline] .
5. Arcidi JM, Moore GW, Hutchins GM. Hepatic morphology in cardiac dysfunction: a clinicopathologic
study of 1000 subjects at autopsy. Am J Pathol. Aug 1981;104(2):159-66. [Medline] .
6. Fava M, Meneses L, Loyola S, Castro P, Barahona F. TIPSS Procedure in the Treatment of a Single
Patient After Recent Heart Transplantation Because of Refractory Ascites Due to Cardiac Cirrhosis.
Cardiovasc Intervent Radiol. December 2007;[Medline] . [Full Text] .
7. Dichtl W, Vogel W, Dunst KM, Grander W, Alber HF, Frick M, et al. Cardiac hepatopathy before and after
heart transplantation. Transpl Int. Jun 2005;18(6):697-702. [Medline] .
8. Cotran RS. Robbins Pathologic Basis of Disease. 6th ed. Philadelphia: WB Saunders Co; 1999:883.
9. Crawford MH. Inspection and Palpation of Venous and Arterial Pulses. American Heart
Association;1990:3-14.
10. Dunn GD, Hayes P, Breen KJ. The liver in congestive heart failure: a review. Am J Med Sci.
1973;265:174.
11. Feldman M. Sleisenger & Fordtran's Gastointestinal and Liver Disease. 1998. 6th ed. Philadelphia: WB
http://emedicine.medscape.com/article/151792-overview
3/4
8/25/2014
http://emedicine.medscape.com/article/151792-overview
4/4